How Testosterone Fell Out of Favor in Medicine — and How It Came Back
Dr. Abraham Morgentaler, a Blavatnik Faculty Fellow in Health and Longevity at Harvard Medical School, has played a pivotal role in reshaping the contemporary understanding of testosterone therapy. Once shunned over fears it fueled prostate cancer, testosterone treatment has been rehabilitated through decades of Morgentaler’s clinical work and research, which demonstrated its safety and meaningful benefits for men with low testosterone. His pioneering efforts helped overturn long-held misconceptions, leading to broader acceptance of testosterone therapy for appropriate patients and a renewed focus on evidence-based care.
